↓ Skip to main content

Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppressed HBV Replication in…

Overview of attention for article published in Frontiers in Pharmacology, October 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
14 X users

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
5 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppressed HBV Replication in Mouse Model
Published in
Frontiers in Pharmacology, October 2021
DOI 10.3389/fphar.2021.756975
Pubmed ID
Authors

Fei-lin Ge, Lan-lan Si, Yan Yang, Yuan-hua Li, Zhong-lin Lv, Wen-hui Liu, Hao Liao, Jun Wang, Jun Zou, Le Li, Hui Li, Zi-lin Zhang, Jia-bo Wang, Xue-chun Lu, Dong-ping Xu, Zhao-fang Bai, Yan Liu, Xiao-he Xiao

X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 5 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 2 40%
Professor 1 20%
Lecturer 1 20%
Student > Master 1 20%
Readers by discipline Count As %
Unspecified 2 40%
Chemistry 2 40%
Pharmacology, Toxicology and Pharmaceutical Science 1 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 May 2022.
All research outputs
#6,417,892
of 25,515,042 outputs
Outputs from Frontiers in Pharmacology
#2,775
of 19,877 outputs
Outputs of similar age
#121,162
of 443,769 outputs
Outputs of similar age from Frontiers in Pharmacology
#163
of 1,140 outputs
Altmetric has tracked 25,515,042 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 19,877 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 443,769 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 1,140 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.